Pancreatic Cancer Research

ResearcherUniversity of TampereNo recent work listed

Anne H. Kallioniemi

Matched on ORCID iD 0000-0003-3552-8158; OpenAlex author ID A5028823431.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
5 (first author 0, last author 5)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper

Papers 5

  1. KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro. Last author DOI 10.1016/j.yexcr.2013.11.014↗
  2. Silencing of the ARP2/3 complex disturbs pancreatic cancer cell migration. Last author PMID 23267127↗
  3. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Last author DOI 10.1002/gcc.21941↗
  4. MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer. Last author DOI 10.1002/ijc.25924↗
  5. Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players. Last author DOI 10.1016/j.yexcr.2011.06.001↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Hanna E. Rauhala · 2 shared papers, 2013–2014
  2. Eeva M. Laurila · 2 shared papers, 2012–2014
  3. Riina Kuuselo · 1 shared paper, 2011
  4. Siru Virtanen · 1 shared paper, 2011

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.